Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Second-line treatment with docetaxel after failure of a platinum-based chemotherapy in squamous-cell head and neck cancer.

× No keyword cloud information.

4 in total

1. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group.

Authors: Athanassios Argiris; Ashley Buchanan; Bruce Brockstein; Jill Kolesar; Musie Ghebremichael; Michael Pins; Kristine Hahn; Rita Axelrod; Arlene Forastiere
Journal: Cancer Date: 2009-10-01 Impact factor: 6.860

2. A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.

Authors: Alan L Ho; Brynna L Lipson; Eric J Sherman; Han Xiao; Matthew G Fury; Arlyn Apollo; Nagashree Seetharamu; Camelia S Sima; Sofia Haque; John K Lyo; Roberta Sales; Lisa Cox; David G Pfister
Journal: Invest New Drugs Date: 2014-02-25 Impact factor: 3.850

3. Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618.

Authors: Susanne M Arnold; James Moon; Stephen K Williamson; James N Atkins; Sai-Hong I Ou; Michael LeBlanc; Susan G Urba
Journal: Invest New Drugs Date: 2009-11-25 Impact factor: 3.850

4. A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Authors: L A Dunn; M G Fury; H Xiao; S S Baxi; E J Sherman; S Korte; C Pfister; S Haque; N Katabi; A L Ho; D G Pfister
Journal: Ann Oncol Date: 2017-10-01 Impact factor: 32.976

4 in total